Deutsche Bank Ag\ Immutep LTD Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$0.72 - $3.03 $1,540 - $6,484	-2,140 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.6 - $1.9 $3,424 - $4,066	2,140 New	2,140 $3,000
Q2 2019 Aug 14, 2019	SELL	$1.74 - $2.16 $20,180 - $25,051	-11,598 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$1.97 - $2.57 $174,230 - $227,295	-88,442 Reduced 88.41%	11,598 $25,000
Q4 2018 Feb 14, 2019	BUY	$1.84 - $3.9 $34,592 - $73,320	18,800 Added 23.14%	100,040 $184,000
Q3 2018 Nov 14, 2018	BUY	$2.45 - $3.7 $199,038 - $300,588	81,240 New	81,240 $300,000

1.86M

264K

90.5K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $176M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.